71336-1003 : Amvuttra 25 mg/.5ml Subcutaneous Injection
NDC: | 71336-1003 |
Labeler: | Alnylam Pharmaceuticals, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Amvuttra |
Dosage Form: | Subcutaneous Injection |
Application #: | NDA215515 |
Rev. Date: |
NDC Package Codes:
- 71336-1003-1: 1 SYRINGE, GLASS IN 1 CARTON (71336‑1003‑1) > .5 ML IN 1 SYRINGE, GLASS
Active Ingredients:
- Vutrisiran
Dosage Strength:
- 25 mg/.5mL
Pharmaceutical Classes:
- Decreased RNA Integrity [PE]
- Increased Protein Breakdown [PE]
- RNA
- Small Interfering [CS]
- Small Interfering RNA [EPC]
- Transthyretin-directed RNA Interaction [EPC]
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 71336-1002Next: 71337-019 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.